• English
    • español
    • português (Brasil)
  • English 
    • English
    • español
    • português (Brasil)
  • Login
View Item 
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
  •   COVID-19
  • Resources in English
  • Technical documents and research evidence on COVID-19
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Epidemiological Update: Novel coronavirus (2019-nCoV) (20 January 2020)

 
Thumbnail
Author
Pan American Health Organization
Metadata
Show full item record
Abstract
Since the Epidemiological Alert on the new coronavirus (2019-nCoV) published on January 16, 2020 and until January 20, 2020 four countries have reported to the World Organization Health (WHO) confirmed cases: China (198 cases, including three deaths, 2 cases in Beijing and 1 case in Guandong, all imported from Wuhan), Japan (1 case, imported from Wuhan, China), Thailand (two cases imported from Wuhan, China) and Republic of Korea (1 case imported from Wuhan, China). According to the information disclosed by the Chinese authorities, an epidemiological investigation led by a national team of experts began on December 31, 2019 and the following public health measures were implemented: case isolation, identification and followup of contacts, environmental sanitation and laboratory research. To date, continues the uncertainty about the new pathogen and the spectrum of manifestations it may cause, the source of infection, the mode of transmission, the incubation period, the severity of the disease and the specific control measures. Current evidence suggests that person-to-person transmission is limited, which would be consistent with what is known about other similar pathogens. However, person-to-person transmission, included in the nosocomial environment, has been documented on a recurring basis for other emerging coronaviruses, such as Severe Acute Respiratory Syndrome (SARS) and the Middle East Respiratory Syndrome-causing Coronavirus (MERS-CoV). Therefore, control measures taken for SARS and MERS can guide the response against this new pathogen.
URI
https://iris.paho.org/bitstream/handle/10665.2/51851/EpiUpdate20January2020_eng.pdf?sequence=1&isAllowed=y
Collections
  • Technical documents and research evidence on COVID-19

Browse

AllCommunities & CollectionsBy Issue DateAuthorsTitlesCategorySubjectsThis CollectionBy Issue DateAuthorsTitlesCategorySubjects

My Account

LoginRegister

Pan American Health Organization
World Health Organization. Regional Office for the Americas
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America

Content Disclaimer (Important notes about the material)

Links

  • WHO International Clinical Trial Registry Platform (ICTRP)
  • WHO Coronavirus disease R&D Blueprint
  • WHO Database of Publications on Coronavirus Disease
  • PAHO Coronavirus Disease
  • PAHO/BIREME Windows of Knowledge COVID-19
  • Evidence aid Coronavirus (COVID-19) resources

  • PAHO Digital Library (IRIS PAHO)
  • Virtual Health Library (VHL)
  • Global Index Medicus (GIM)